South Korea
· Delayed Price · Currency is KRW SD Biosensor Statistics
Total Valuation
SD Biosensor has a market cap or net worth of KRW 1.26 trillion. The enterprise value is 1.46 trillion.
| Market Cap | 1.26T |
| Enterprise Value | 1.46T |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
SD Biosensor has 119.62 million shares outstanding. The number of shares has increased by 4.81% in one year.
| Current Share Class | 119.62M |
| Shares Outstanding | 119.62M |
| Shares Change (YoY) | +4.81% |
| Shares Change (QoQ) | -1.73% |
| Owned by Insiders (%) | 32.26% |
| Owned by Institutions (%) | 3.51% |
| Float | 32.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.79 |
| PB Ratio | 0.44 |
| P/TBV Ratio | 1.57 |
| P/FCF Ratio | 21.30 |
| P/OCF Ratio | 9.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.00, with an EV/FCF ratio of 24.79.
| EV / Earnings | -13.80 |
| EV / Sales | 2.08 |
| EV / EBITDA | 18.00 |
| EV / EBIT | n/a |
| EV / FCF | 24.79 |
Financial Position
The company has a current ratio of 4.95, with a Debt / Equity ratio of 0.22.
| Current Ratio | 4.95 |
| Quick Ratio | 3.18 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 7.77 |
| Debt / FCF | 10.70 |
| Interest Coverage | -0.84 |
Financial Efficiency
Return on equity (ROE) is -3.67% and return on invested capital (ROIC) is -1.06%.
| Return on Equity (ROE) | -3.67% |
| Return on Assets (ROA) | -0.96% |
| Return on Invested Capital (ROIC) | -1.06% |
| Return on Capital Employed (ROCE) | -1.60% |
| Revenue Per Employee | 1.22B |
| Profits Per Employee | -183.92M |
| Employee Count | 576 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 1.64 |
Taxes
| Income Tax | -122.25B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.74% in the last 52 weeks. The beta is 0.97, so SD Biosensor's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +5.74% |
| 50-Day Moving Average | 10,375.40 |
| 200-Day Moving Average | 10,203.50 |
| Relative Strength Index (RSI) | 40.41 |
| Average Volume (20 Days) | 253,459 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SD Biosensor had revenue of KRW 703.51 billion and -105.94 billion in losses. Loss per share was -871.90.
| Revenue | 703.51B |
| Gross Profit | 341.14B |
| Operating Income | -58.47B |
| Pretax Income | -228.03B |
| Net Income | -105.94B |
| EBITDA | 81.20B |
| EBIT | -58.47B |
| Loss Per Share | -871.90 |
Balance Sheet
The company has 432.25 billion in cash and 630.74 billion in debt, giving a net cash position of -198.49 billion or -1,659.39 per share.
| Cash & Cash Equivalents | 432.25B |
| Total Debt | 630.74B |
| Net Cash | -198.49B |
| Net Cash Per Share | -1,659.39 |
| Equity (Book Value) | 2.88T |
| Book Value Per Share | 24,004.10 |
| Working Capital | 706.62B |
Cash Flow
In the last 12 months, operating cash flow was 128.25 billion and capital expenditures -69.28 billion, giving a free cash flow of 58.97 billion.
| Operating Cash Flow | 128.25B |
| Capital Expenditures | -69.28B |
| Free Cash Flow | 58.97B |
| FCF Per Share | 492.98 |
Margins
Gross margin is 48.49%, with operating and profit margins of -8.31% and -15.06%.
| Gross Margin | 48.49% |
| Operating Margin | -8.31% |
| Pretax Margin | -32.41% |
| Profit Margin | -15.06% |
| EBITDA Margin | 11.54% |
| EBIT Margin | -8.31% |
| FCF Margin | 8.38% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 1.83%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 1.83% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.81% |
| Shareholder Yield | -2.99% |
| Earnings Yield | -8.43% |
| FCF Yield | 4.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SD Biosensor has an Altman Z-Score of 1.84 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.84 |
| Piotroski F-Score | 5 |